Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a05:640c:1195:b0:1eb:e128:bbe3 with SMTP id o21csp115687eip;
        Wed, 17 Jan 2024 15:12:13 -0800 (PST)
X-Google-Smtp-Source: AGHT+IG3YIplPF56wPH1S/c9uX8Gb0cSdSHte37FKi8yK6Fr2plvztnPDrZQW9SM06rYfVojPLCb
X-Received: by 2002:a05:620a:280c:b0:783:4c3c:917c with SMTP id f12-20020a05620a280c00b007834c3c917cmr2156224qkp.24.1705533133400;
        Wed, 17 Jan 2024 15:12:13 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705533133; cv=none;
        d=google.com; s=arc-20160816;
        b=BqSJLz3HrpRnlmwvOm6DfeZxNHGzbzkO1OTzI1ZDy4lXSJ9eLQn4NdkeKF4DGP7a6t
         QD5YSokFjrjBZjOz5us10URtn4LN2Z10rL1cFvHZTQdOuXXvQYJnyiCs4AhlsYD9PtH8
         jmuJCSV1JpUTUYmuwAQhXTiuRzDe++kXo3cdgrvayr/KYsZ1oWMtCMU/oYFF6x1rMXep
         ifNnCMq8UYqbWbu0okA2uzn942IlNtBv3we+Y9exm9DiFO8k+U2bNRJEQRpcrxQff6At
         CDYLvF0R86UFe9OXZ/R07PDLdpTmir2QPT1JP6++rk7bYMJqKmdsV7gwcnOFYV4XJKgC
         7Qbw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=pVlb09PDxT1K0RUpOEn6sv2WgTFV6NM7QTd4HloypVA=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=ZLU162yTNgNwCIEzxLz0SfrNOTm0KFj9StAhQpj+sjbPgobvuB/a3wil3bYp9TW+rR
         Y1RHq+h04dQM+5bdjYsQHumFc4AR3A7fkOzYqaVR4gbxemkRo35BQeOjiNqgvW9ecD8N
         ESNi/jbuVVMZIh99rSpyP8AX2Wb6XoLWsgMfag7JZ9EOFhTaXe58FBA3mT6yJ0iSTtFL
         pZGRtHaIlHxjlXn3oT5r3csKT1zLNP+88s9Rq9T8j3dUqtN2uJwJjZEYoaFNGS7dUCHa
         xEVBNkfLFHOF35nWqWVNY7xfB3e63xw/h7jd37+KteoPXNv3rhesi8pMlZmZSHwqH/ng
         ct+g==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=iUY63YHR;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=v4kTVzjI;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id k1-20020a05620a0b8100b007831ff3b688si12370499qkh.777.2024.01.17.15.12.13
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Wed, 17 Jan 2024 15:12:13 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=iUY63YHR;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=v4kTVzjI;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=pVlb09PDxT1K0RUpOEn6sv2WgTFV6NM7QTd4HloypVA=;
	b=iUY63YHRqTC5WmexLjIQ4OOBXti6H05//HNlAX2aoZM4qVXVPnD4xi+T5oUESplpEES5
	jSnTI9zGnsRO9x4FabjiTtiXuuoWU/1qLcHo40oknn5M9lqLjBl8BVyPUhXHzKC356sYl/
	U+LJENzMs7wejPKGEzkB2GS90qcy8PchQGTwmBPPxAduVQf4NDyEJ14s2FDxDDdwN2QVy9
	q0Y4DhZ5z+ACcFVSjSMvMELLttBLfYDJRIH+jtrOEInrkahfaJ+n2G7a0I20pxQwNDvCmB
	jIC4ctioIzEfOaARWHn50Cw6gV1KyTTM+gO5IVLkFWkn3ZXbxSR2EVNNzYT/Av4g==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=pVlb09PDxT1K0RUpOEn6sv2WgTFV6NM7QTd4HloypVA=;
	b=v4kTVzjIr01FA834ZZEsF9J7rYKgB2NWg+8A2/Hyo+99MMUyRe+GG8x0PC3tl4DVIiiC
	lTDL2tDpEoAf3IQ7Wp2saCt9UW/r3ivfz8gFxKYSSVNDM0gqo+L0Eikir2OPIFwUNfZyHw
	SKVYKitoPtmWMu5xeW9DPZgRLvMCLViDI=
Received: by filterdrecv-647c69fd5c-86wk4 with SMTP id filterdrecv-647c69fd5c-86wk4-1-65A85ECB-72
        2024-01-17 23:12:11.902354704 +0000 UTC m=+7965022.412169941
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-34 (SG) with HTTP
	id lK2FFPrgQr-THpoDB5PYDg
	Wed, 17 Jan 2024 23:12:11.897 +0000 (UTC)
Content-Type: multipart/alternative; boundary=a01c55f7d59af83e5dad47e6418c9fb04ebcb28cb2b0692def2af6a3cf32
Date: Wed, 17 Jan 2024 23:12:13 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <lK2FFPrgQr-THpoDB5PYDg@geopod-ismtpd-34>
Subject: PRO/AH/EDR> COVID-19 update (06): India, decrease in cases
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBOL2m5Rdetu2q8+VXWHD0ct40UFZHz6LUwmx3d?=
 =?us-ascii?Q?3nKuTcFz=2F3es1YCtqh8flkdS8+8940RcnNJL+1S?=
 =?us-ascii?Q?2AjEfI0e7=2FUZkyQYSO7JbefTzD7x7vO4xhKZ8PY?=
 =?us-ascii?Q?ycZS9p5IukvgZ0gv3IR9GmWgx=2F1PtwYfhRoK9w=2F?=
 =?us-ascii?Q?NTdBtqGHivIDzheJ+jEFKxxkEHdAD8MpgDuFS4?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUiShGf=2FO8XJWpH34Od4Nd?=
 =?us-ascii?Q?fxXa6jil96uRcJkF+N+LeVnO1tx80ddOyoyOo=2Fc?=
 =?us-ascii?Q?Brxcl3ERAm0cOY743=2FFH59DWiSf5OzXORh1DLKt?=
 =?us-ascii?Q?hb1NMKty3PsA5ju0ZzxCrq1WQuZSEQf=2FJlWtgqv?=
 =?us-ascii?Q?cZmsyCHlNUZsDnFVRXSZeylv9UcdvYT5vTI0kC5?=
 =?us-ascii?Q?7OPo9mN1sHGW6oCNV=2FeSUDGc6C5vIdi+gtVxpgG?=
 =?us-ascii?Q?I0q1rZaVqhJjLLjRocRVCAQWojzNPN9OhdFg71Y?=
 =?us-ascii?Q?j7O5yZEAjrE8mwrOnrn8sCqX2sH0fqzmAFHCBeq?=
 =?us-ascii?Q?u5qdcBWwRdO+33QApz72Sl6VSdENSJUO2hrwOKY?=
 =?us-ascii?Q?ntyL65so7DxlvHpDqcATRzZ2g7F=2F+O6if=2F+xIJh?=
 =?us-ascii?Q?ym3wL59Tm6g1FhqYMO1O1lVlaO5g=2Fdw+zkY25jX?=
 =?us-ascii?Q?1Wl5CjKGxP8enHcI5372n9B+WsQIPNBprkK+Pgh?=
 =?us-ascii?Q?KABZ5hhN7=2FNX7eeXEiG6BtZlUqwY6xHhxB6O89s?=
 =?us-ascii?Q?GUwrcBzchOjtQlU=2FSCAynbkh=2FV8zcSLy1JifDyj?=
 =?us-ascii?Q?xdl=2FTLlA+Su+ylSjDt3d5Ti7=2F6IoPp+8sT2jU0t?=
 =?us-ascii?Q?XgduKCEuqfrdcbgxR32lBUc55rTEwBQGCsvXbch?=
 =?us-ascii?Q?1XUfOUM=2FSJaYvrpxMW47F3=2F9P+1Tl=2Fhsy75LDQC?=
 =?us-ascii?Q?lec2=2FqrS2uIywod3363fLOuhNduehcuHQ3QziIV?=
 =?us-ascii?Q?oXr0GqGKyLGTvdA4aBvweu=2FfqqjeYYCjVh3Ndn4?=
 =?us-ascii?Q?53gI3Fnre9se5i+kXC+7KC=2FsIg=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2ELefXtDPUP?=
 =?us-ascii?Q?Ac9ymSqQgKSv5gvsy2X-uQHfZSiaTJMbgtoMDAw?=
 =?us-ascii?Q?dTAwMKXjQPAIwpu-szSKuxLvfVkjOwlqnjdHm1=5F?=
 =?us-ascii?Q?ttxtx02Vjs6Bhe7EhOvHPZnAzbxhp5VzT08jh1G?=
 =?us-ascii?Q?xmaZRDc9W4dKvR4d8edHOsU7Hg3BS4V2K4SHU0k?=
 =?us-ascii?Q?Zgcy7eeAMsGMS6aYA=3D=3D=2EICk2QY0ZgFsYPzX7kgG?=
 =?us-ascii?Q?kNjkdhxBSNwVkJhLLsQJIq11oMDAwdTAwMD9Fhr?=
 =?us-ascii?Q?isY2JWGIF3wjojaNgmGjlUTzyXgp520QU4VR6UQ?=
 =?us-ascii?Q?2lR2HlyJNyEUKzuov5KPA9wodGcQsljHsrNl4cn?=
 =?us-ascii?Q?ly6tclmKkqvllPdrOdzI5-QKOBanw6qXKEXofI=5F?=
 =?us-ascii?Q?VAGpVmnohq=5F0oLAHVMc6aNO2XqwAYsDodT8NRLE?=
 =?us-ascii?Q?xRSI=5FB79vjT3P1r5uTQJUIqGrnJoFHSAiCF5EKs?=
 =?us-ascii?Q?x8GC9lhKZeV9PF4vnU2Eaded-p3mRy7sJSfQR30?=
 =?us-ascii?Q?YusRmEv-n9CpGCMqd03ADApTeXjUVYRmEbpXYn0?=
 =?us-ascii?Q?wOreq21DMxuYJlvGmNPz6Da4hheswTvGjZRbMyv?=
 =?us-ascii?Q?4e9Pi2B50SRtgC6r=5FycY5eM8naumqvPVSUeo-C3?=
 =?us-ascii?Q?XyumU9VQoou3G4ZFO3YYHnKauPgFM8OKA1n-TRl?=
 =?us-ascii?Q?=5FTwgkp7YiP=5FEKMs=5FKeTz-pWMb6cDmMlkYkB11X6?=
 =?us-ascii?Q?sZZCTfjfBCdCWWqW25Pzj1BTFuaNLkyImfVJt4E?=
 =?us-ascii?Q?ptvZihswv1rONZ8vdMLf-vEK1z4DB1XJxMS4yew?=
 =?us-ascii?Q?q3K5DEV9pEytZCAELQUd0S2oLKjdBVciKXZ2nLZ?=
 =?us-ascii?Q?Zp46rAUSURBLGHbDVlWxr6PQer91qmE6H-q7yOa?=
 =?us-ascii?Q?RdNe2Ukm1ufA9B9=5FvN6Fx7MuNFA4TgLdZjzk4aL?=
 =?us-ascii?Q?TLNq-=5FNTckHWsyiZICprILsgb5iklTUNRDzwOeG?=
 =?us-ascii?Q?3XPxb8Eyvs-I=5FcxcuwjxSX1eN2luWhbnJoFk8v2?=
 =?us-ascii?Q?Fbs1KCEA=5FMvZVX6jhaXUsHzTCOevcAkf7Miu9ua?=
 =?us-ascii?Q?inwoW3RO6XFTomOzXW9oq7VwGyd5cbyyoBQEl3-?=
 =?us-ascii?Q?R1u0DG2UVauJJB3x1BbnwdbT-Au0rWbZEdrPAlY?=
 =?us-ascii?Q?98DFwqycAmsipqdGSxa1MWSbZQQYX=5F-EV49akCf?=
 =?us-ascii?Q?7qh50Zd5rx9aIkHOP1w8EVVBpopR0afXM0-Mj31?=
 =?us-ascii?Q?2t=5FVc-Ad9AwUiiuOESLuGO8uKDHNVJdwmbqMNmU?=
 =?us-ascii?Q?OufZl3tVg7dJC4UFX9gitT8R070=5FF4YXk96WNj0?=
 =?us-ascii?Q?XKHk9lJjCCESuxacqsRs6T8Ha7hVCoQzclM41=5Fp?=
 =?us-ascii?Q?8JM2BA=3D=3D=3E?=

--a01c55f7d59af83e5dad47e6418c9fb04ebcb28cb2b0692def2af6a3cf32
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

CORONAVIRUS DISEASE 2019 UPDATE (06): INDIA, DECREASE IN CASES
**************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Mon 15 Jan 2024
Source: The Weather Channel [edited]
<https://weather.com/en-IN/india/coronavirus/news/2024-01-15-india-register=
s-25-percent-decline-in-covid19-cases>


After 5 consecutive weeks of rising COVID-19 cases and anxieties,
India finally witnessed a 25% dip in the viral infection during the
week ending on 13 Jan 2024. And this encouraging trend was accompanied
by a decline in deaths, with 22 reported compared to 31 the previous
week.

As of Sunday [14 Jan 2024], India logged 375 new cases of COVID-19,
while the number of active infections has dropped to 3075, the Health
Ministry said. Although a new variant and colder weather conditions
initially drove the surge, the situation now seems to be stabilising.
The good news is widespread too, with most major states registering a
drop in reported infections.

Kerala led the pack with a nearly 60% reduction, from 1109 cases last
week to 452 this week. Even Karnataka and Maharashtra, which were
previously witnessing a surge, saw a gratifying decline. Karnataka,
still with the highest case count at 1583, had dropped from 1856
previously, while Maharashtra reported a dip from 915 to 709.

Bengal remains a concern as it continues to see a rise in infections.
But experts are closely monitoring the situation and urging strict
adherence to safety protocols to prevent further spread.

While the recent developments offer a glimmer of hope amidst concerns
about the new JN.1 sub-variant, a new INSACOG [Indian SARS-CoV Genomic
Consortium] report indicates that we cannot let our guards down just
yet.

According to INSACOG data, the JN.1 sub-variant has crossed the 1000
mark nationwide. Karnataka has been revealed to be the leading hotspot
with 214 cases, followed by Andhra Pradesh (189) and Maharashtra
(170). Even as concerns remain about JN.1, official sources assure
there's no evidence of it triggering an exponential increase in cases
or a surge in hospitalisations and deaths.

Given the decrease in active COVID-19 cases, we do have reason for
some cautious optimism. However, the JN.1 variant requires close
monitoring, and continued vaccination efforts remain essential to
bolster population immunity. Continued vigilance, coupled with
responsible social distancing and adherence to safety protocols, can
help solidify this downward trend and prevent future surges.

[Byline: Ashmita Gupta]

--
Communicated by:
ProMED
via
ProMED-SoAs

[The slight temporal surge of COVID-19 cases as started across India a
few weeks back, suspected to have been triggered due to introduction
and spread of the omicron sub-variant JN.1, is perhaps in a declining
phase after reaching the peak, as indicated in the news report above.
It is a matter of great satisfaction that this sub-variant has not
become a serious issue in the country, although the case counts
attributed to the sub-variant are being still monitored cautiously.

Of note, "JN.1 is closely related to the variant BA.2.86.... It is not
currently known whether JN.1 infection produces different symptoms
from other variants. In general, symptoms of COVID-19 tend to be
similar across variants. The types of symptoms and how severe they are
usually depend more on a person's immunity and overall health rather
than which variant causes the infection"
(<https://www.cdc.gov/respiratory-viruses/whats-new/SARS-CoV-2-variant-JN.1=
.html>).
- Mod.PKB

ProMED map of India:
<https://promedmail.org/promed-post?place=3D8714266,142>]

[See Also:
COVID-19 update (05): Pakistan, JN.1, variant of interest
http://promedmail.org/post/20240111.8714166
COVID-19 update (04): selected locations, JN.1 virology, severity,
omicron BA.4.1 in dogs
Archive Number: http://promedmail.org/post/20240111.8714155
COVID-19 update (03): Israel, JN.1, new variant
http://promedmail.org/post/20240104.8714055
COVID-19 update (02): India
http://promedmail.org/post/20240103.8714052
COVID-19 update (01): Cambodia, new JN.1 variant detection
http://promedmail.org/post/20240101.8714020
2023
----
COVID-19 update (39): Saudi Arabia, JN.1 variant, MOH
http://promedmail.org/post/20231222.8713858
COVID-19 update (38): WHO classifies JN.1 coronavirus strain as
'variant of interest' http://promedmail.org/post/20231220.8713808
COVID-19 update (37): vaccine comp., selected regions, circ. variants,
research http://promedmail.org/post/20231219.8713789
COVID-19 update (36): selected countries/regions, vaccines
http://promedmail.org/post/20231212.8713666
COVID-19 update (35): Singapore, increase
http://promedmail.org/post/20231209.8713618
COVID-19 update (34): selected country/region updates, variants, WHO
http://promedmail.org/post/20231130.8713398
COVID-19 update (33): country updates, vaccines, vaccine refusal, WHO
update http://promedmail.org/post/20231105.8713000
COVID-19 update (32): updates, variants, vaccines, antivirals,
scientific literature http://promedmail.org/post/20231026.8712809
COVID-19 update (31): BA.2.86 & EG.5, selected regions, vaccines, WHO,
global http://promedmail.org/post/20231009.8712522
COVID-19 update (30): omicron EG.5.1, updates, WHO, global
http://promedmail.org/post/20230815.8711701
COVID-19 update (29): updates, wastewater surveillance, transmission,
WHO, global http://promedmail.org/post/20230802.8711526
COVID-19 update (28): superspread, masks, vaccination, WHO, global
http://promedmail.org/post/20230724.8711339
COVID-19 update (27): vaccination, test kit distribution, sequelae,
WHO, global http://promedmail.org/post/20230717.8711208
COVID-19 update (26): animal, North America, wild deer as reservoirs
http://promedmail.org/post/20230713.8711124
COVID-19 update (25): vaccines, liver disease, sequelae, WHO, global
http://promedmail.org/post/20230713.8711095
COVID-19 update (24): long-term effects, EU.1.1, wild bat, WHO, global
http://promedmail.org/post/20230704.8710946
COVID-19 update (23): EU transition plan, viral emission, vacc
hesitancy, GBS, WHO http://promedmail.org/post/20230619.8710662
COVID-19 update (22): trends, immunity, children, metformin, WHO
http://promedmail.org/post/20230612.8710546
COVID-19 update (21): countries, life expectancy, long COVID,
research, WHO, global http://promedmail.org/post/20230605.8710423
COVID-19 update (20): countries, Paxlovid, vaccine, WHO
http://promedmail.org/post/20230530.8710317
COVID-19 update (19): countries, vaccine composition, XBB1.16, WHO,
global http://promedmail.org/post/20230522.8710178
COVID-19 update (18): country/regional, vaccine policies, vaccination,
WHO, global http://promedmail.org/post/20230516.8710088
COVID-19 update (17): WHO, USA, India, China, XBB.1.16, research,
global http://promedmail.org/post/20230508.8709926
COVID-19 update (16): XBB.1.16, reinfections, microglia, sequelae,
WHO, global http://promedmail.org/post/20230502.8709789
COVID-19 update (15): India, XBB.1.16, fetal brain damage, HCW, global
http://promedmail.org/post/20230417.8709526
COVID-19 update (14): countries, vaccines, XBB.1.16, long COVID, WHO
http://promedmail.org/post/20230407.8709377
COVID-19 update (13): India, surveillance, HCW, rats, infant
hospitalizations, WHO, global
http://promedmail.org/post/20230329.8709196
COVID-19 update (12): countries, variants, susceptibility, vaccines,
WHO, global http://promedmail.org/post/20230321.8709066
COVID-19 update (11): country responses, complications, treatment,
WHO, global http://promedmail.org/post/20230312.8708900
COVID-19 update (10): Hong Kong, XBB.1.5, Iran, UAE, bivalent vacc
http://promedmail.org/post/20230308.8708776
COVID-19 update (09): XBB.1.5, vaccine, WHO
http://promedmail.org/post/20230228.8708641
COVID-19 update (08): countries, immunity, vaccines, treatment, masks,
WHO, global http://promedmail.org/post/20230219.8708482
COVID-19 update (07): countries, molnupiravir, vaccines, PACS,
cockroach, WHO http://promedmail.org/post/20230212.8708331
COVID-19 update (06): China, demographics, symptoms, PACS, WHO
http://promedmail.org/post/20230204.8708165
COVID-19 update (05): PHEIC continues, WHO
http://promedmail.org/post/20230130.8708059
COVID-19 update (04): PHEIC, China, susp outbreaks, responses,
vaccines, global http://promedmail.org/post/20230130.8708043
COVID-19 update (03): China, guidelines, vacc, immunity, sequelae, WHO
http://promedmail.org/post/20230122.8707910
COVID-19 update (02): China, XBB.1.5, Hong Kong, mAb, pathogenesis,
WHO, global http://promedmail.org/post/20230115.8707786
COVID-19 update (01): China, Hong Kong, XBB.1.5, PAHO, treatment,
testing, WHO http://promedmail.org/post/20230107.8707667
2022
----
COVID-19 update (193): surge, travel restrictions, screening,
treatment, WHO http://promedmail.org/post/20221230.8707528
COVID-19 update (191): omicron BF.7, bivalent vaccines, China, WHO,
global http://promedmail.org/post/20221224.8707437
COVID-19 update (190): China, Australia, vaccines, sequelae, WHO,
global http://promedmail.org/post/20221219.8707306
COVID-19 update (189): mortality, mAb, intranasal vacc, NPIs,
sequelae, WHO, global http://promedmail.org/post/20221209.8707146
COVID-19 update (188): China, omicron BA.2.76, outdoor transmission
http://promedmail.org/post/20221130.8706983
COVID-19 update (187): boosters, omicron BQ.1.1, Asia, Australia, WHO,
global http://promedmail.org/post/20221129.8706920
COVID-19 update (185): chr. COVID, bladder, recovery, renal, deaths,
WHO, global http://promedmail.org/post/20221111.8706665
COVID-19 update (184): vaccination response, disparity, WHO, global
http://promedmail.org/post/20221104.8706549
COVID-19 update (183): cardiac events, exercise, US deaths, boosters,
WHO, global http://promedmail.org/post/20221028.8706414
COVID-19 update (182): frontline workers, life expectancy,
subvariants, WHO, global http://promedmail.org/post/20221021.8706286
COVID-19 update (181): Africa vacc hesitancy, pre-eclampsia, boosters,
nasal vacc, WHO, global http://promedmail.org/post/20221014.8706143
COVID-19 update (180): long COVID, neuropsy. illness, Paxlovid,
subvariants, WHO http://promedmail.org/post/20221007.8706007
COVID-19 update (170): case severity, boosters, physical activity,
WHO, global http://promedmail.org/post/20220825.8705236
COVID-19 update (160): vaccine rollout disparities, smell & taste,
WHO, global http://promedmail.org/post/20220731.8704776
COVID-19 update (150): France, omicron 2nd gen variant, paxlovid, WHO,
global http://promedmail.org/post/20220705.8704255
COVID-19 update (140): Thailand, human to cat to human transmission
http://promedmail.org/post/20220612.8703819
COVID-19 update (130): surveill., cardiac eff., long COVID subtypes,
WHO, global http://promedmail.org/post/20220601.8703606
COVID-19 update (120): N Korea, pandemic exit, youth vaccine, US
deaths, WHO http://promedmail.org/post/20220518.8703327
COVID-19 update (110): mutations, mental health, China, S Africa,
Paxlovid, WHO http://promedmail.org/post/20220505.8703018
COVID-19 update (100): vacc. intervals, deaths, long COVID,
subvariants, global http://promedmail.org/post/20220420.8702717
COVID-19 update (90): strategy, 2nd booster, WHO
http://promedmail.org/post/20220407.8702454
COVID-19 update (80): animal, USA, deer, transmission
http://promedmail.org/post/20220325.8702212
COVID-19 update (70): case count, UK, BA.2, USA, WHO, global
http://promedmail.org/post/20220312.8701940
COVID-19 update (60): animal, China, origin, research
http://promedmail.org/post/20220227.8701690
COVID-19 update (50): Hong Kong, estrogen risk, maternal vaccine
benefits, WHO http://promedmail.org/post/20220217.8701501
COVID-19 update (40): Denmark, rosemary, pregnancy, stroke, WHO
http://promedmail.org/post/20220205.8701276
COVID-19 update (30): variants in immuno-comp., stability, endemic,
WHO http://promedmail.org/post/20220126.8701074
COVID-19 update (20): Africa vacc., Taiwan, waning immunity,
persistence, global http://promedmail.org/post/20220117.8700915
COVID-19 update (10): animal, omicron origin statement, OIE
http://promedmail.org/post/20220110.8700763
COVID-19 update (01): omicron severity & changes, Germany, T-cell
reactivity http://promedmail.org/post/20220101.8700616]
.................................................pkb/rd/pkb/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DZBjfpzHD2hIEjdFI769tPnGe6wdZd9FqM8YOUT-QzW5oMDAwdTAwMJ5jwvn=
niGeWgtQRGaWFaKeyV85a_de674n2gKC4qJpvuTckceGZjh3RC-CeUiMQ9pgq-4AXMH8Ew2vMGT=
Y-bqmTdmJFYlc9jP03zDFk9rLGOK5z7FoM9Ned_aj_1cCPf-dg1BYlgDM-_i-VNV33pKJZHMB1C=
lcoxo74JpviYNzTE79sLUIhUNvomFKXCF2MVmgmRnNMP6JpnBuk1Fhad6juWni5iJxEm5H3E6Mq=
bOxnGOoD7QTeQM7YrhaFSEtSJ1FZOD0sQqSJ_MN_kXvw1rLtArcLPlkoxfWV5EonWfyNe8S31ky=
2psPwM8qqgvQgx9EYAFRlgdR1HqFsFbYSDp6QoI9J7MzGvLWFYQWoYpdGMtboWjotubjyJCJUWz=
to4n8eZSgSncPGxSAvS_raEnbGTwj--qrJeHO_YTCzL10n64D69SW1RmCvCdcP867dGm0x2qxP_=
3mNiLxvm25eD58eMmXlAedP6HK7tFNYFozRBfx87Z7NDD2zwyEurAx3qXWVQXyLYSQSEiz5WegK=
7Q5u6TWYCMZADeojCxOBHMNaPfKtpAPL95-o1DHB8TZGKvV2vl3JbE_XS7pEUroUPnuPKgDhyvD=
MNwLAFPXvgX4SFTGQ5hBWSpcshvM72dCqWKWdriVJcpHxME9tKxl5qAo-7CKVem20OMo_pSusXD=
Bw3H3lZMD2bPc-hqwjRZYbYRp2JYeYKtF5z-Pvj3VNXZ1g1rY-LpEM3fi-8gmU9D44BDsTDlL7d=
VFJQCkQvsVuIR8VR3yG0hRs74fxED_nrdiEnkSQLZFs_GhAI0FJNflTp0Zp71wwn5iEqVK-HuXw=
8Ru0Qin61OBZhiG4R4FWstMfrxaQ0GdPAmfzjklyMHVhzx8H3jzNpkJirprIFOluMnnDnDGWSgk=
_kUAg1TIWI5m-cF8HOnC37NwvJMD04SoP2hRlSPVnKANItzMbgFjGHj-7MWbP4lfzNbgc8jY2Ee=
2J7T4Rqy1rH-vEFQIVXwfVCx2p3F5Nzj8HfkyKwSHmzhm2FIUOITvnfy-GPmw5iP8MY3BppD6c9=
g2EIuuUIGGXzd7VnT2SaLfyqB7HjZ64Qp7fBhqHPQshmDaIywrgD9feGUPP2x1dsxL-WawWxPCQ=
8HS8AvBYTQo5-bT1aEtwiHNzriLZJRJuwJgCnsX2kPDWp_TuYCXOQCS2jaKPFBZv )
############################################################
############################################################

--a01c55f7d59af83e5dad47e6418c9fb04ebcb28cb2b0692def2af6a3cf32
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>CORONAVIRUS DISEASE 2019 UPDATE (06): INDIA, DECREASE IN CASES<br>***=
***********************************************************<br>A ProMED-mai=
l post<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPI=
t48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/432/bauI-Jd4QN-6eFpXNoBJr=
w/h0/XtK1y2wfchzHGjBgUUCsqtc8gmlngShjWBgfJ9V6ebA">http://www.promedmail.org=
</a><br>ProMED-mail is a program of the<br>International Society for Infect=
ious Diseases<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5=
fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/432/bauI-Jd4QN-6eFpXNoBJrw/h1/7_fDdH_Pb=
Zq_XECQgYoJZGBTgbmXrWMDAipuoGgx6ZM">http://www.isid.org</a><br><br>Date: Mo=
n 15 Jan 2024=0D<br>Source: The Weather Channel [edited]=0D<br><a href=3D"h=
ttps://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMam1zsrfK9HaZynkND1=
_SoDvkv41chn6IB3uWXEy3I4XdFYOST8q6hEMfolqIezE0PPM6IdUHltEiyin5UO_H7Vn8mVAPk=
OCGf9a8z9b4dU_S1gd5z3amvNHsiTI2zKxwfVObOWtt2TrO58JBP0_f9lYY/432/bauI-Jd4QN-=
6eFpXNoBJrw/h2/L2lLEo2b6bohbq0QCFvJ9lX5rEjfB5juRiyoHF-m5R4">https://weather=
.com/en-IN/india/coronavirus/news/2024-01-15-india-registers-25-percent-dec=
line-in-covid19-cases</a>=0D<br>=0D<br>=0D<br>After 5 consecutive weeks of =
rising COVID-19 cases and anxieties,<br>India finally witnessed a 25% dip i=
n the viral infection during the<br>week ending on 13 Jan 2024. And this en=
couraging trend was accompanied<br>by a decline in deaths, with 22 reported=
 compared to 31 the previous<br>week.=0D<br>=0D<br>As of Sunday [14 Jan 202=
4], India logged 375 new cases of COVID-19,<br>while the number of active i=
nfections has dropped to 3075, the Health<br>Ministry said. Although a new =
variant and colder weather conditions<br>initially drove the surge, the sit=
uation now seems to be stabilising.<br>The good news is widespread too, wit=
h most major states registering a<br>drop in reported infections.=0D<br>=0D=
<br>Kerala led the pack with a nearly 60% reduction, from 1109 cases last<b=
r>week to 452 this week. Even Karnataka and Maharashtra, which were<br>prev=
iously witnessing a surge, saw a gratifying decline. Karnataka,<br>still wi=
th the highest case count at 1583, had dropped from 1856<br>previously, whi=
le Maharashtra reported a dip from 915 to 709.=0D<br>=0D<br>Bengal remains =
a concern as it continues to see a rise in infections.<br>But experts are c=
losely monitoring the situation and urging strict<br>adherence to safety pr=
otocols to prevent further spread.=0D<br>=0D<br>While the recent developmen=
ts offer a glimmer of hope amidst concerns<br>about the new JN.1 sub-varian=
t, a new INSACOG [Indian SARS-CoV Genomic<br>Consortium] report indicates t=
hat we cannot let our guards down just<br>yet.=0D<br>=0D<br>According to IN=
SACOG data, the JN.1 sub-variant has crossed the 1000<br>mark nationwide. K=
arnataka has been revealed to be the leading hotspot<br>with 214 cases, fol=
lowed by Andhra Pradesh (189) and Maharashtra<br>(170). Even as concerns re=
main about JN.1, official sources assure<br>there's no evidence of it trigg=
ering an exponential increase in cases<br>or a surge in hospitalisations an=
d deaths.=0D<br>=0D<br>Given the decrease in active COVID-19 cases, we do h=
ave reason for<br>some cautious optimism. However, the JN.1 variant require=
s close<br>monitoring, and continued vaccination efforts remain essential t=
o<br>bolster population immunity. Continued vigilance, coupled with<br>resp=
onsible social distancing and adherence to safety protocols, can<br>help so=
lidify this downward trend and prevent future surges.=0D<br>=0D<br>[Byline:=
 Ashmita Gupta]=0D<br>=0D<br>--=0D<br>Communicated by:=0D<br>ProMED=0D<br>v=
ia=0D<br>ProMED-SoAs<br><br>[The slight temporal surge of COVID-19 cases as=
 started across India a<br>few weeks back, suspected to have been triggered=
 due to introduction<br>and spread of the omicron sub-variant JN.1, is perh=
aps in a declining<br>phase after reaching the peak, as indicated in the ne=
ws report above.<br>It is a matter of great satisfaction that this sub-vari=
ant has not<br>become a serious issue in the country, although the case cou=
nts<br>attributed to the sub-variant are being still monitored cautiously.=0D=
<br>=0D<br>Of note, "JN.1 is closely related to the variant BA.2.86.... It =
is not<br>currently known whether JN.1 infection produces different symptom=
s<br>from other variants. In general, symptoms of COVID-19 tend to be<br>si=
milar across variants. The types of symptoms and how severe they are<br>usu=
ally depend more on a person's immunity and overall health rather<br>than w=
hich variant causes the infection"<br>(<a href=3D"https://u19268662.ct.send=
grid.net/ss/c/TLh_csrC34X_iXpbYoMam_PtI61miXazSyoEfBLPyZKA-oy1NYMDc-KHzSzK1=
98WSueDAT_qLmLlfSgJkC7EAP8LWW62Dhe_YYGeJNRyd5RbE379RzhTFV3CEVH9ZVg9/432/bau=
I-Jd4QN-6eFpXNoBJrw/h3/i5HE4djPSmoTawjiHSpm-Zll4LXKZTsc8LyO4B66mwk">https:/=
/www.cdc.gov/respiratory-viruses/whats-new/SARS-CoV-2-variant-JN.1.html</a>=
).<br>- Mod.PKB=0D<br>=0D<br>ProMED map of India:<br><a href=3D"https://u19=
268662.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6Wbk=
fhqXYXU-aTMPJ8yThiyXutpm34KZhFiZdozIYCw/432/bauI-Jd4QN-6eFpXNoBJrw/h4/9wLEZ=
AwJFLatSE3EdqO5L7qFLwgMslA4egSfv2RMKe4">https://promedmail.org/promed-post?=
place=3D8714266,142</a>]<br><br>[See Also:<br>COVID-19 update (05): Pakista=
n, JN.1, variant of interest<br>http://promedmail.org/post/20240111.8714166=0D=
<br>COVID-19 update (04): selected locations, JN.1 virology, severity,<br>o=
micron BA.4.1 in dogs=0D<br>Archive Number: http://promedmail.org/post/2024=
0111.8714155=0D<br>COVID-19 update (03): Israel, JN.1, new variant<br>http:=
//promedmail.org/post/20240104.8714055=0D<br>COVID-19 update (02): India<br=
>http://promedmail.org/post/20240103.8714052=0D<br>COVID-19 update (01): Ca=
mbodia, new JN.1 variant detection<br>http://promedmail.org/post/20240101.8=
714020=0D<br>2023=0D<br>----=0D<br>COVID-19 update (39): Saudi Arabia, JN.1=
 variant, MOH<br>http://promedmail.org/post/20231222.8713858=0D<br>COVID-19=
 update (38): WHO classifies JN.1 coronavirus strain as<br>'variant of inte=
rest' http://promedmail.org/post/20231220.8713808=0D<br>COVID-19 update (37=
): vaccine comp., selected regions, circ. variants,<br>research http://prom=
edmail.org/post/20231219.8713789=0D<br>COVID-19 update (36): selected count=
ries/regions, vaccines<br>http://promedmail.org/post/20231212.8713666=0D<br=
>COVID-19 update (35): Singapore, increase<br>http://promedmail.org/post/20=
231209.8713618=0D<br>COVID-19 update (34): selected country/region updates,=
 variants, WHO<br>http://promedmail.org/post/20231130.8713398=0D<br>COVID-1=
9 update (33): country updates, vaccines, vaccine refusal, WHO<br>update ht=
tp://promedmail.org/post/20231105.8713000=0D<br>COVID-19 update (32): updat=
es, variants, vaccines, antivirals,<br>scientific literature http://promedm=
ail.org/post/20231026.8712809=0D<br>COVID-19 update (31): BA.2.86 & EG.5, s=
elected regions, vaccines, WHO,<br>global http://promedmail.org/post/202310=
09.8712522=0D<br>COVID-19 update (30): omicron EG.5.1, updates, WHO, global=
<br>http://promedmail.org/post/20230815.8711701=0D<br>COVID-19 update (29):=
 updates, wastewater surveillance, transmission,<br>WHO, global http://prom=
edmail.org/post/20230802.8711526=0D<br>COVID-19 update (28): superspread, m=
asks, vaccination, WHO, global<br>http://promedmail.org/post/20230724.87113=
39=0D<br>COVID-19 update (27): vaccination, test kit distribution, sequelae=
,<br>WHO, global http://promedmail.org/post/20230717.8711208=0D<br>COVID-19=
 update (26): animal, North America, wild deer as reservoirs<br>http://prom=
edmail.org/post/20230713.8711124=0D<br>COVID-19 update (25): vaccines, live=
r disease, sequelae, WHO, global<br>http://promedmail.org/post/20230713.871=
1095=0D<br>COVID-19 update (24): long-term effects, EU.1.1, wild bat, WHO, =
global<br>http://promedmail.org/post/20230704.8710946=0D<br>COVID-19 update=
 (23): EU transition plan, viral emission, vacc<br>hesitancy, GBS, WHO http=
://promedmail.org/post/20230619.8710662=0D<br>COVID-19 update (22): trends,=
 immunity, children, metformin, WHO<br>http://promedmail.org/post/20230612.=
8710546=0D<br>COVID-19 update (21): countries, life expectancy, long COVID,=
<br>research, WHO, global http://promedmail.org/post/20230605.8710423=0D<br=
>COVID-19 update (20): countries, Paxlovid, vaccine, WHO<br>http://promedma=
il.org/post/20230530.8710317=0D<br>COVID-19 update (19): countries, vaccine=
 composition, XBB1.16, WHO,<br>global http://promedmail.org/post/20230522.8=
710178=0D<br>COVID-19 update (18): country/regional, vaccine policies, vacc=
ination,<br>WHO, global http://promedmail.org/post/20230516.8710088=0D<br>C=
OVID-19 update (17): WHO, USA, India, China, XBB.1.16, research,<br>global =
http://promedmail.org/post/20230508.8709926=0D<br>COVID-19 update (16): XBB=
.1.16, reinfections, microglia, sequelae,<br>WHO, global http://promedmail.=
org/post/20230502.8709789=0D<br>COVID-19 update (15): India, XBB.1.16, feta=
l brain damage, HCW, global<br>http://promedmail.org/post/20230417.8709526=0D=
<br>COVID-19 update (14): countries, vaccines, XBB.1.16, long COVID, WHO<br=
>http://promedmail.org/post/20230407.8709377=0D<br>COVID-19 update (13): In=
dia, surveillance, HCW, rats, infant<br>hospitalizations, WHO, global<br>ht=
tp://promedmail.org/post/20230329.8709196=0D<br>COVID-19 update (12): count=
ries, variants, susceptibility, vaccines,<br>WHO, global http://promedmail.=
org/post/20230321.8709066=0D<br>COVID-19 update (11): country responses, co=
mplications, treatment,<br>WHO, global http://promedmail.org/post/20230312.=
8708900=0D<br>COVID-19 update (10): Hong Kong, XBB.1.5, Iran, UAE, bivalent=
 vacc<br>http://promedmail.org/post/20230308.8708776=0D<br>COVID-19 update =
(09): XBB.1.5, vaccine, WHO<br>http://promedmail.org/post/20230228.8708641=0D=
<br>COVID-19 update (08): countries, immunity, vaccines, treatment, masks,<=
br>WHO, global http://promedmail.org/post/20230219.8708482=0D<br>COVID-19 u=
pdate (07): countries, molnupiravir, vaccines, PACS,<br>cockroach, WHO http=
://promedmail.org/post/20230212.8708331=0D<br>COVID-19 update (06): China, =
demographics, symptoms, PACS, WHO<br>http://promedmail.org/post/20230204.87=
08165=0D<br>COVID-19 update (05): PHEIC continues, WHO<br>http://promedmail=
.org/post/20230130.8708059=0D<br>COVID-19 update (04): PHEIC, China, susp o=
utbreaks, responses,<br>vaccines, global http://promedmail.org/post/2023013=
0.8708043=0D<br>COVID-19 update (03): China, guidelines, vacc, immunity, se=
quelae, WHO<br>http://promedmail.org/post/20230122.8707910=0D<br>COVID-19 u=
pdate (02): China, XBB.1.5, Hong Kong, mAb, pathogenesis,<br>WHO, global ht=
tp://promedmail.org/post/20230115.8707786=0D<br>COVID-19 update (01): China=
, Hong Kong, XBB.1.5, PAHO, treatment,<br>testing, WHO http://promedmail.or=
g/post/20230107.8707667=0D<br>2022=0D<br>----=0D<br>COVID-19 update (193): =
surge, travel restrictions, screening,<br>treatment, WHO http://promedmail.=
org/post/20221230.8707528=0D<br>COVID-19 update (191): omicron BF.7, bivale=
nt vaccines, China, WHO,<br>global http://promedmail.org/post/20221224.8707=
437=0D<br>COVID-19 update (190): China, Australia, vaccines, sequelae, WHO,=
<br>global http://promedmail.org/post/20221219.8707306=0D<br>COVID-19 updat=
e (189): mortality, mAb, intranasal vacc, NPIs,<br>sequelae, WHO, global ht=
tp://promedmail.org/post/20221209.8707146=0D<br>COVID-19 update (188): Chin=
a, omicron BA.2.76, outdoor transmission<br>http://promedmail.org/post/2022=
1130.8706983=0D<br>COVID-19 update (187): boosters, omicron BQ.1.1, Asia, A=
ustralia, WHO,<br>global http://promedmail.org/post/20221129.8706920=0D<br>=
COVID-19 update (185): chr. COVID, bladder, recovery, renal, deaths,<br>WHO=
, global http://promedmail.org/post/20221111.8706665=0D<br>COVID-19 update =
(184): vaccination response, disparity, WHO, global<br>http://promedmail.or=
g/post/20221104.8706549=0D<br>COVID-19 update (183): cardiac events, exerci=
se, US deaths, boosters,<br>WHO, global http://promedmail.org/post/20221028=
.8706414=0D<br>COVID-19 update (182): frontline workers, life expectancy,<b=
r>subvariants, WHO, global http://promedmail.org/post/20221021.8706286=0D<b=
r>COVID-19 update (181): Africa vacc hesitancy, pre-eclampsia, boosters,<br=
>nasal vacc, WHO, global http://promedmail.org/post/20221014.8706143=0D<br>=
COVID-19 update (180): long COVID, neuropsy. illness, Paxlovid,<br>subvaria=
nts, WHO http://promedmail.org/post/20221007.8706007=0D<br>COVID-19 update =
(170): case severity, boosters, physical activity,<br>WHO, global http://pr=
omedmail.org/post/20220825.8705236=0D<br>COVID-19 update (160): vaccine rol=
lout disparities, smell & taste,<br>WHO, global http://promedmail.org/post/=
20220731.8704776=0D<br>COVID-19 update (150): France, omicron 2nd gen varia=
nt, paxlovid, WHO,<br>global http://promedmail.org/post/20220705.8704255=0D=
<br>COVID-19 update (140): Thailand, human to cat to human transmission<br>=
http://promedmail.org/post/20220612.8703819=0D<br>COVID-19 update (130): su=
rveill., cardiac eff., long COVID subtypes,<br>WHO, global http://promedmai=
l.org/post/20220601.8703606=0D<br>COVID-19 update (120): N Korea, pandemic =
exit, youth vaccine, US<br>deaths, WHO http://promedmail.org/post/20220518.=
8703327=0D<br>COVID-19 update (110): mutations, mental health, China, S Afr=
ica,<br>Paxlovid, WHO http://promedmail.org/post/20220505.8703018=0D<br>COV=
ID-19 update (100): vacc. intervals, deaths, long COVID,<br>subvariants, gl=
obal http://promedmail.org/post/20220420.8702717=0D<br>COVID-19 update (90)=
: strategy, 2nd booster, WHO<br>http://promedmail.org/post/20220407.8702454=0D=
<br>COVID-19 update (80): animal, USA, deer, transmission<br>http://promedm=
ail.org/post/20220325.8702212=0D<br>COVID-19 update (70): case count, UK, B=
A.2, USA, WHO, global<br>http://promedmail.org/post/20220312.8701940=0D<br>=
COVID-19 update (60): animal, China, origin, research<br>http://promedmail.=
org/post/20220227.8701690=0D<br>COVID-19 update (50): Hong Kong, estrogen r=
isk, maternal vaccine<br>benefits, WHO http://promedmail.org/post/20220217.=
8701501=0D<br>COVID-19 update (40): Denmark, rosemary, pregnancy, stroke, W=
HO<br>http://promedmail.org/post/20220205.8701276=0D<br>COVID-19 update (30=
): variants in immuno-comp., stability, endemic,<br>WHO http://promedmail.o=
rg/post/20220126.8701074=0D<br>COVID-19 update (20): Africa vacc., Taiwan, =
waning immunity,<br>persistence, global http://promedmail.org/post/20220117=
.8700915=0D<br>COVID-19 update (10): animal, omicron origin statement, OIE<=
br>http://promedmail.org/post/20220110.8700763=0D<br>COVID-19 update (01): =
omicron severity & changes, Germany, T-cell<br>reactivity http://promedmail=
.org/post/20220101.8700616]<br>............................................=
.....pkb/rd/pkb/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DZBjfpzHD2hIEjdFI769tPnGe6wdZd9FqM8YOUT-QzW5oMDAwdT=
AwMJ5jwvnniGeWgtQRGaWFaKeyV85a_de674n2gKC4qJpvuTckceGZjh3RC-CeUiMQ9pgq-4AXM=
H8Ew2vMGTY-bqmTdmJFYlc9jP03zDFk9rLGOK5z7FoM9Ned_aj_1cCPf-dg1BYlgDM-_i-VNV33=
pKJZHMB1Clcoxo74JpviYNzTE79sLUIhUNvomFKXCF2MVmgmRnNMP6JpnBuk1Fhad6juWni5iJx=
Em5H3E6MqbOxnGOoD7QTeQM7YrhaFSEtSJ1FZOD0sQqSJ_MN_kXvw1rLtArcLPlkoxfWV5EonWf=
yNe8S31ky2psPwM8qqgvQgx9EYAFRlgdR1HqFsFbYSDp6QoI9J7MzGvLWFYQWoYpdGMtboWjotu=
bjyJCJUWzto4n8eZSgSncPGxSAvS_raEnbGTwj--qrJeHO_YTCzL10n64D69SW1RmCvCdcP867d=
Gm0x2qxP_3mNiLxvm25eD58eMmXlAedP6HK7tFNYFozRBfx87Z7NDD2zwyEurAx3qXWVQXyLYSQ=
SEiz5WegK7Q5u6TWYCMZADeojCxOBHMNaPfKtpAPL95-o1DHB8TZGKvV2vl3JbE_XS7pEUroUPn=
uPKgDhyvDMNwLAFPXvgX4SFTGQ5hBWSpcshvM72dCqWKWdriVJcpHxME9tKxl5qAo-7CKVem20O=
Mo_pSusXDBw3H3lZMD2bPc-hqwjRZYbYRp2JYeYKtF5z-Pvj3VNXZ1g1rY-LpEM3fi-8gmU9D44=
BDsTDlL7dVFJQCkQvsVuIR8VR3yG0hRs74fxED_nrdiEnkSQLZFs_GhAI0FJNflTp0Zp71wwn5i=
EqVK-HuXw8Ru0Qin61OBZhiG4R4FWstMfrxaQ0GdPAmfzjklyMHVhzx8H3jzNpkJirprIFOluMn=
nDnDGWSgk_kUAg1TIWI5m-cF8HOnC37NwvJMD04SoP2hRlSPVnKANItzMbgFjGHj-7MWbP4lfzN=
bgc8jY2Ee2J7T4Rqy1rH-vEFQIVXwfVCx2p3F5Nzj8HfkyKwSHmzhm2FIUOITvnfy-GPmw5iP8M=
Y3BppD6c9g2EIuuUIGGXzd7VnT2SaLfyqB7HjZ64Qp7fBhqHPQshmDaIywrgD9feGUPP2x1dsxL=
-WawWxPCQ8HS8AvBYTQo5-bT1aEtwiHNzriLZJRJuwJgCnsX2kPDWp_TuYCXOQCS2jaKPFBZv" =
target=3D"_blank" class=3D"Unsubscribe--unsubscribePreferences" style=3D"fo=
nt-family:sans-serif;text-decoration:none;">Unsubscribe Preferences</a></di=
v><br>############################################################<br>#####=
#######################################################<br><br><img src=3D"=
https://u19268662.ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/432/bauI-Jd4Q=
N-6eFpXNoBJrw/ho.gif" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=
=3D"height:1px !important;width:1px !important;border-width:0 !important;ma=
rgin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;=
margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !importa=
nt;padding-right:0 !important;padding-left:0 !important;"/></body>
</html>
--a01c55f7d59af83e5dad47e6418c9fb04ebcb28cb2b0692def2af6a3cf32--
